Merit Financial Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.68M | Buy |
64,529
+2,530
| +4% | +$226K | 0.04% | 349 |
|
|
2026
Q1 | $4.45M | Buy |
61,999
+8,487
| +16% | +$654K | 0.03% | 421 |
|
|
2025
Q4 | $4.25M | Buy |
53,512
+11,502
| +27% | +$907K | 0.03% | 395 |
|
|
2025
Q3 | $3.17M | Buy |
42,010
+2,494
| +6% | +$171K | 0.03% | 425 |
|
|
2025
Q2 | $2.73M | Sell |
39,516
-3,137
| -7% | -$206K | 0.03% | 428 |
|
|
2025
Q1 | $2.89M | Buy |
42,653
+26,084
| +157% | +$1.56M | 0.04% | 333 |
|
|
2024
Q4 | $744K | Sell |
16,569
-54
| -0.3% | -$3.03K | 0.01% | 587 |
|
|
2024
Q3 | $1.05M | Sell |
16,623
-5,325
| -24% | -$311K | 0.02% | 416 |
|
|
2024
Q2 | $1.3M | Sell |
21,948
-5,003
| -19% | -$313K | 0.03% | 352 |
|
|
2024
Q1 | $1.51M | Buy |
26,951
+12,718
| +89% | +$971K | 0.04% | 315 |
|
|
2023
Q4 | $1.12M | Sell |
14,233
-6,639
| -32% | -$473K | 0.03% | 284 |
|
|
2023
Q3 | $1.46M | Sell |
20,872
-3,605
| -15% | -$255K | 0.05% | 266 |
|
|
2023
Q2 | $1.69M | Buy |
24,477
+6,596
| +37% | +$469K | 0.05% | 248 |
|
|
2023
Q1 | $1.33M | Sell |
17,881
-1,908
| -10% | -$160K | 0.05% | 251 |
|
|
2022
Q4 | $1.84M | Buy |
19,789
+1,236
| +7% | +$119K | 0.07% | 210 |
|
|
2022
Q3 | $1.77M | Buy |
18,553
+5,640
| +44% | +$558K | 0.08% | 170 |
|
|
2022
Q2 | $1.2M | Buy |
12,913
+5,115
| +66% | +$499K | 0.04% | 235 |
|
|
2022
Q1 | $789K | Sell |
7,798
-2,396
| -24% | -$252K | 0.05% | 180 |
|
|
2021
Q4 | $1.05M | Buy |
10,194
+57
| +0.6% | +$5.27K | 0.1% | 92 |
|
|
2021
Q3 | $860K | Sell |
10,137
-65
| -0.6% | -$5.45K | 0.09% | 114 |
|
|
2021
Q2 | $851K | Buy |
10,202
+131
| +1% | +$10.7K | 0.08% | 111 |
|
|
2021
Q1 | $758K | Buy |
10,071
+654
| +7% | +$47.6K | 0.08% | 113 |
|
|
2020
Q4 | $643K | Buy |
9,417
+255
| +3% | +$16.6K | 0.06% | 114 |
|
|
2020
Q3 | $535K | Buy |
9,162
+530
| +6% | +$33K | 0.05% | 133 |
|
|
2020
Q2 | $561K | Sell |
8,632
-235
| -3% | -$14.8K | 0.06% | 117 |
|
|
2020
Q1 | $526K | Sell |
8,867
-17
| -0.2% | -$1.14K | 0.06% | 120 |
|
|
2019
Q4 | $660K | Buy |
8,884
+3,016
| +51% | +$212K | 0.06% | 114 |
|
|
2019
Q3 | $370K | Buy |
5,868
+499
| +9% | +$29.6K | 0.04% | 105 |
|
|
2019
Q2 | $292K | Buy |
5,369
+145
| +3% | +$7.81K | 0.03% | 94 |
|
|
2019
Q1 | $281K | Buy |
5,224
+763
| +17% | +$47.1K | 0.03% | 98 |
|
|
2018
Q4 | $292K | Buy |
4,461
+107
| +2% | +$7.99K | 0.04% | 86 |
|
|
2018
Q3 | $342K | Sell |
4,354
-278
| -6% | -$19.9K | 0.05% | 83 |
|
|
2018
Q2 | $298K | Buy |
4,632
+24
| +0.5% | +$1.58K | 0.05% | 91 |
|
|
2018
Q1 | $286K | Buy |
4,608
+778
| +20% | +$55.8K | 0.06% | 89 |
|
|
2017
Q4 | $277K | Buy |
+3,830
| New | +$278K | 0.06% | 93 |
|
Other funds holding CVS
Merit Financial Group's CVS Position: Q2 2026 in Review
Merit Financial Group increased its CVS Health (CVS) stake by 4.1% in Q2 2026, buying an estimated $226K and bringing the position to 64,529 shares worth $6.68M. The position accounts for 0.04% of the portfolio, ranked #349.
Merit Financial Group first reported a position in CVS in Q4 2017 and has held it in 35 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Merit Financial Group held 64,529 shares of CVS Health worth $6.68M as of Q2 2026.
- Merit Financial Group bought 2,530 CVS Health shares in Q2 2026, an estimated $226K.
- CVS Health made up 0.04% of Merit Financial Group's portfolio in Q2 2026, its #349 holding.
- Merit Financial Group first reported a position in CVS Health in Q4 2017 and has held it in 35 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.